Skip to main content
. 2023 Aug 17;14:1209526. doi: 10.3389/fpsyg.2023.1209526

Table 1.

Univariable associations of patient characteristics with the outcome of any acute care (AC) Visits by 1-year follow-up.

Any AC visit n (%) No AC visit n (%) P-value
Age, median (interquartile range) 60.6 (52.0–70.1) 63.1 (53.6–70.1) 0.44
Sex 0.14
Female 19 (45.2%) 106 (57.9%)
Male 23 (54.8%) 77 (42.1%)
Race and ethnicity 0.91
White non-Hispanic 30 (71.4%) 138 (75.4%)
Any Hispanic or Latino 7 (16.7%) 25 (13.7%)
Black or African American Non-Hispanic 4 (9.5%) 15 (8.2%)
Asian Non-Hispanic 1 (2.4%) 5 (2.7%)
Education 0.90
Less than high school 1 (2.4%) 4 (2.2%)
High school or GED 6 (14.3%) 37 (20.2%)
Some college, associate degree or trade certification 17 (40.5%) 72 (39.3%)
College degree (BS, BA) 10 (23.8%) 43 (23.5%)
Graduate degree (MS, MA) 5 (11.9%) 18 (9.8%)
Advanced degree (PhD, MD, JD) 3 (7.1%) 8 (4.4%)
No response 0 (0.0%) 1 (0.6%)
Household income 0.50
$0–$19,999 3 (7.3%) 16 (8.8%)
$20,000–$49,999 11 (26.8%) 30 (16.6%)
$50,000–$74,999 6 (14.6%) 32 (17.7%)
$75,000 or more 21 (51.2%) 103 (56.9%)
Insurance 1.00
Employer or marketplace-based 23 (54.7%) 99 (54.1%)
Medicaid 1 (2.4%) 5 (2.7%)
Medicare 17 (40.5%) 74 (40.4%)
Other 1 (2.4%) 5 (2.7%)
Cancer type < 0.001
Breast 7 (16.7%) 75 (41.0%)
Central nervous system 1 (2.4%) 3 (1.6%)
Gastrointestinal 11 (26.2%) 13 (7.1%)
Gynecological 3 (7.1%) 4 (2.2%)
Head and neck 8 (19.1%) 18 (9.8%)
Leukemia/lymphoma/myeloma 4 (9.5%) 11 (6.0%)
Lung 6 (14.3%) 18 (9.8%)
Prostate 0 (0.0%) 28 (15.3%)
Other 2 (4.8%) 13 (7.1%)
Disease extent 0.001
Local 7 (16.7%) 90 (49.2%)
Regional 16 (38.1%) 50 (27.3%)
Distant 15 (35.7%) 35 (19.1%)

The bold values indicate P < 0.05.